Viewing Study NCT02571569


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-02-20 @ 8:07 PM
Study NCT ID: NCT02571569
Status: COMPLETED
Last Update Posted: 2018-10-18
First Post: 2015-10-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemophilia A View
None Hemophilia B View
Keywords: